Landsvirkjun Secures ECA Financing from Japan for Theistareykir Geothermal Power Plant
Landsvirkjun has signed an ECA (Export Credit Agency) loan agreement in relation to a supply contract for two 45 MW geothermal turbines from Fuji Electric for the Theistareykir Geothermal Power Plant, scheduled to commence operation in 2017.
The Japan Bank for International Cooperation (JBIC) provided buyer's credit totaling up to USD 34 million (JBIC's portion) at a fixed interest rate. Citibank Japan Ltd. (lead arranger), Bank of Yokohama and Commerzbank AG, Tokyo Branch, co-financed up to USD 34 million at a floating rate, with Nippon Export and Investment Insurance (NEXI) providing insurance, bringing the total financing amount to up to USD 68 million.
JBIC/NEXI-backed financing has achieved a 20 year tenor without a guarantee of collection. This is the first JBIC-NEXI buyer’s credit facility for a renewable energy project within High Income OECD Countries. The JBIC/NEXI-backed financing was supported by Takanawa Japan KK, as an Advisor, and Citigroup, as a Coordinator.
Hordur Arnarson, CEO said: “This is a milestone agreement for Iceland and Japan since this is the first ECA financing Iceland has received from Japan. We are very pleased with the support from the Japanese institutions to finance our first geothermal renewable energy project.”
Rafnar Larusson, +354 515 9000
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
MA-QUADIENT25.6.2018 16:32 | pressemeddelelse
Quadient Announces General Availability of Quadient Inspire R12
DEMENTIA-DISCOVERY-FUND25.6.2018 15:02 | pressemeddelelse
The Dementia Discovery Fund Raises $350 Million
INSTITUT-CURIE25.6.2018 14:24 | pressemeddelelse
Professor Thierry Philip Takes Office as OECI President
BOEHRINGER-INGELHEIM25.6.2018 14:09 | pressemeddelelse
Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
CA-GILEAD-SCIENCES25.6.2018 14:05 | pressemeddelelse
European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection
ANT-FINANCIAL/25.6.2018 14:02 | pressemeddelelse
AlipayHK and GCash Launch Cross-Border Remittance Service Powered by Alipay’s Blockchain Technology
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum